OSO Medical

Website
HealthTech,AI

Company Bio

Founders

LvlUp insightsGenerated from LvlUp’s portfolio data and the company’s own updates
Similar companies

More in the LvlUp portfolio

See all →

Building something ambitious?

LvlUp Ventures backs founders from first check to late stage.

Apply for funding
Rohit Mane, Paul Friedrichs
Pre-Seed
United States
HealthTech, AI
2023
Imagine the world with minimal invasive procedure you can activate the most powerful tool in the human body: Adaptive Immune System. This is the vision for OSO Medical. Our initial target is Lung Cancer. Despite advances in cancer therapy, over 120,000 patients die from Lung cancer in US. What's truly unique about OSO is our intelligent detect and treat algorithm which detects and analyzes tissue in real time, compares its characteristics against our proprietary tissue identity profiles and determines the appropriate therapy dose for that tissue. Instead of delivering predefined dose to every patient and hope for the best outcome, we are creating a closed loop personalized treatment system based on the tissue to control and get the best outcome. We are looking for investors to come on board to continue to support our fundraising effort.

We are developing a novel tech called Pulse Field Immunotherapy which is designed to not only destroy targeted tumor but also maximize the release of tumor antigen while changing tumor microenvironment from immune suppression to activation. Teaching patient's own body to recognize and kill cancer.